Innovent Gains FDA Fast Track for Cancer Drug
January 27, 2026 | 14:25
The biopharmaceutical company received expedited development designation from American regulators for its trispecific antibody treating relapsed or refractory multiple myeloma patients.
FDA Greenlights IND for NTS071, Nutshell Therapeutics’ Cancer Drug
May 05, 2025 | 10:00
New p53 reactivator targets rare Y220C mutation with breakthrough potential.
AstraZeneca to build 1.5 billion USD cancer drug facility in Singapore
May 21, 2024 | 16:28
British pharmaceutical company AstraZeneca announced on May 20 its intention to build a 1.5 billion USD facility in Singapore to produce new generation cancer treatment drugs.
Mobile Version